EPA Chooses CodeLink for Aquatic Toxicity Study; GE to Continue CodeLink Post-merger | GenomeWeb

The US Environmental Protection Agency last week announced that it had selected Amersham Biosciences’s CodeLink microarrays to perform gene-expression experiments to discover biomarkers for aquatic toxicity.

Financial details of the agreement were not disclosed.

The deal, however, served to launch a new custom design and manufacturing service for Amersham, which is slated to merge with General Electric.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.